Stay updated on NVG-111 in ROR1+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.

Latest updates to the NVG-111 in ROR1+ Malignancies Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe clinical trial record for NVG-111 is now displayed, including its study design, eligibility criteria, locations, outcomes, and record details, instead of an access-denied error.SummaryDifference56%

- Check17 days agoChange DetectedThe ClinicalTrials.gov site revision was updated from v3.7.2 to v3.8.0 in the footer, while the study record continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA notice announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. It appears above the study record’s 403 error.SummaryDifference1%

- Check30 days agoChange DetectedThe footer’s site revision changes from v3.7.1 to v3.7.2 while the 403 Forbidden error page remains otherwise unchanged.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link, indicating restricted access and replacing the previous study content.SummaryDifference19%

Stay in the know with updates to NVG-111 in ROR1+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NVG-111 in ROR1+ Malignancies Clinical Trial page.